Portfolio Companies News
October 20, 2021Targovax ASA appoints Dr. Erik Digm...
Oslo, Norway, 20 October 2021 – Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, today announces the appointment of Dr. Erik Digman Wiklund as Chief Executive Officer (CEO). Dr. Wiklund has intimate knowledg... read more
October 19, 2021Germany is world’s first country ...
Berlin/Hamburg, 19 October 2021 – The digital therapeutic HelloBetter Stress and Burnout has been permanently approved by the Federal Institute for Drugs and Medical Devices (BfArM) as a Digital Health Application (DiGA) and thus is available by prescription. It is the world’s f... read more
October 19, 2021Nordic Nanovector enters research c...
Oslo, Norway, 19 October 2021 Nordic Nanovector ASA (OSE: NANOV) is pleased to announce that it has entered into a research collaboration with the University of Pennsylvania ("Penn") to generate a CD37-targeting CAR-T cell approach as a potential treatment for patients with B-cell mali... read more
October 12, 2021Lakeside is the first healthcare pr...
Doctrin – a Swedish healthtech company – has for the last five years proven its ability to transform access to and delivery of care, care continuity, patient experience and efficiency in the Nordics. Doctrin is now going live with its digital platform in the UK to support digitally enabled tran... read more
October 7, 2021Aro Biotherapeutics Appoints Mittie...
Dr. Doyle brings more than 20 years of clinical development experience in industry and academia to Aro’s leadership team Philadelphia, PA, October 7, 2021 – Aro Biotherapeutics, a biotechnology company pioneering the development of tissue-targeted genetic medicines, today announc... read more
July 22, 2021Q2 2021 General Market Overview
October 07, 2021HealthCap strengthens senior team
Since the start in 1996, HealthCap funds have invested in 123 portfolio companies.
46 of the portfolio companies have been taken public on nine different markets.
29 of the portfolio companies pharmaceutical products have been approved for marketing.
Since the start in 1996, HealthCap has helped build 12 companies with a valuation of USD 1 billion or more.